pharma end to end supply chain cogress 2014 11-12 december

To Book Call: +44 (0) 207 193 3485 • Email: [email protected] • Web: www.paradigmglobalevents.com

11 – 12 December 2014 • Hilton lonDon Kensington Hotel, lonDon, UniteD KingDom

Pharma End-to-End Supply Chain 2014Rethinking and Transforming the Future of thePharmaceutical Supply Chain

Book Now!

Early Bird &Group discount

availaBlE

The two – day Congress will provide an interactive and intimate discussion and networking format led by key industry expert speakers with intimate knowledge in the industry. Gain practical strategies and best practices on challenges, innovations, technologies and concept surrounding pharmaceutical End – to – End supply chain.

Gain latest insights on:

• European distribution landscape: Effect on Commercial Activities in Europe

• supply chain on trends: Preserving Profit Margins for Pharmaceutical Companies

• asia supply chain risk: Understanding the Asia Marketplace• Gdp: How Does It Affect Pharmaceutical Companies• supply chain security: Key Trends Driving the Need for

Supply Chain Security• vendor Management: Choosing the Right Partner• integrity of the pharmaceutical supply chain: Delivering Safe

and Effective Medication Therapy to Patients• looking into the Future: Forces Reshaping the Industry

Featuring key Industry Experts

Johnathon MarshallPharma & Life Sciences Advisory partner, pwc

Birk vanderweeenHead of Supply Planning Analytics, Global Supply Chain & Strategy, astraZEnEca

christopher GallwasHead of Networking Planning (GPO), BoEhrinGEr inGElhEiM

Janice KiteTraceability Director Healthcare, Gs1

Martin FitzGeraldDeputy Director General, Girp

richard BergströmDirector General, EFpia (EuropEan FEdEration oF pharMacEutical industriEs and associations)

tom cochraneHead of Security Operations, napp pharMacEuticals

dr. Michael richterClinical Demand and Supply Leader, rochE

Michele ingravalloDirector of Business Innovation and Transformation,alliancE Boots

scott a. lawsonPharma & Life Sciences Advisory director, pwc

olivier simonnotStrategic Market Manager Life Science EMEA, sEnsitEch EMEa, the netherlands

MEDIA PARTNERS & SUPPORTED By:

SPONSORED By:

ExHIBITOR:

https://www.facebook.com/ParadigmGlobalEvents?fref=ts

https://twitter.com/ParadigmGlobal

https://www.linkedin.com/company/paradigm-global-events


REGISTER Now!early birD & groUp DiscoUnt available!To register contact: yara O’dulajaEmail: [email protected]: +44 (0) 207 624 2454

Venue Information

hilton london KEnsinGton179-199 Holland Park Avenue, LondonW11 4Ul, United KingdomTel: +44-207-603-3355 | Fax: 44-207-602-9397Email: [email protected]

PharmaEnd-to-End Supply Chain 2014Rethinking and Transforming the Future of the Pharmaceutical Supply Chain

dear colleagues,

The pharmaceutical sector has been impacted by the recent global financial crisis. There are ranges of mechanisms that governments are using to rein in pharmaceutical spending and these are being implemented in various ways across the region. And dome of these mechanisms affect the supply chain for pharmaceutical products.

pharma End-to-End supply chain 2014 Europe provide an unique platform for business knowledge sharing and convergence of top tier government, hospitals, pharmaceuticals, biotechnology, non-profit organisations, as well as regional and local manufacturers to discuss and share on the macroeconomic factors, policies, issues and drivers that will steer the evolving supply chain in the pharmaceutical industry.

who will You Meet

presidents, heads / chiefs, directors, vps and Managers of:

• SupplyChainStrategy&Management• Logistics• Sourcing/Procurement• Distribution• Transportation• Planning• Operations• DemandManagement• SupplierRelations• Security• Integrity• Risk• Anti-Counterfeiting

I look forward to meeting you at the conference.

Best Regards,

JocElyn raGuindinConference Directorparadigm Global [email protected]

By Attending you will be exposed to:

• NewTechnologies,InnovationsandConcept

• NewProductandTrends

• AddressingthecommonissuesandSolutionstoovercome

• NetworkingwithServiceProviders

• Establish,networkandsourceopportunitieswithmajorsuppliers

• Gainnewideasthatoffersrealvaluetoyourbusiness

• Listentokeyindustryexpertspeakerswhoareintheknowanddiscussmajorissueswithabroadrangeofotherseniorlevelbusinessexecutiveleadersandestablishrapport


Diagnostic companies. This role continued a common thread throughout her career of roles at various stages of the extended supply chain with the trend of moving downstream closer to the external customer. She has held a number of positions with medical device industry associations: ABHI and Eucomed.

Her MBA dissertation (Hypothesis: Medical Device manufacturer applied or embedded RFID has benefits to Patient Safety over existing Auto-ID technologies, e.g. Bar Codes) received critical acclaim.


Martin FitzGerald, deputy to the Director General, advises the association on a matrix of pharmaceutical and legal issues impacting upon the interests of the pharmaceutical full-line wholesale sector in Europe.

He also represents the association externally and in this respect works with the European institutions such as the European Commission, the European Parliament and the Council as well as with other European and International organisations such as the Council of Europe and the WHO. Another important part of his work consists in liaising with European stakeholder associations and national health authorities.


Richard Bergström has been the Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) since April 2011. Previously he served for nine years as the Director-General of LIF, the Swedish Association of the Pharmaceutical Industry, following positions in Switzerland in regulatory affairs at the pharmaceutical companies Roche and Novartis.

Mr Bergström was also appointed by the Swedish Government to the Board of the Karolinska Institute. He is a pharmacist by training, receiving his MScPharm degree from the University of Uppsala, Sweden in 1988.

Michele ingravalloDirector of Business Innovation and Transformation, alliancE Boots

Michele Ingravallo, Director of Business Innovation and Transformation in Alliance Boots, is responsible for driving and managing the performance of the Alcura organisation / Brand and businesses related across all the countries and divisional operation, and providing the strategic direction and support to the local operations.

Also he is responsible for driving the business innovation process for all the business brands in the pharmaceutical wholesale division of Alliance Boots. He possesses European pharmaceutical experience and he has developed the strategic direction for healthcare and specialised services in the European and Chinese Markets.

Michele is a graduate professor in Science, Technology and Maths. He is an MBA Candidate from the University of Bradford - School of Management. Within Alliance Boots, he has held a number of senior positions in the last 9 years where he has developed a series of clinical services for Pharmaceutical Manufacturers, hospitals and CROs. Prior to Alliance Boots, Michele held a number of senior roles in reengineering and consultancy positions in Coca Cola Company, and within the Telecommunication, Bank and the Oil sectors.

About the Speakers

Johnathon MarshallPharma & Life Sciences Advisory partner, pwc

Johnathon is a Partner in PwC’s Pharmaceutical and Life Sciences sector heading up the European supply chain team. He has considerable consulting experience in the Pharmaceutical and Life Sciences industry and experience with FMCG industries. He has worked with a range of leading global Pharmaceutical and BioPharma companies to deliver new business and supply chain models, from initial design concept through to implementation. Recent experience has focused on the design of agile supply models presenting greater cost base flexibility through the adoption of structures proven in adjacent industry sectors.

His experience spans both commercial and investigating pharmaceutical supply chain. Johnathon has worked at all levels within client organizations, covering both commercial, sales and R&D functions. He works across geographies, supporting clients from the US, Europe, Nordics and Japan. Johnathon has a BSc (Hons) in Geography from the University of St Andrews.

Birk vanderweeenHead of Supply Planning Analytics, Global Supply Chain & Strategy, astraZEnEca

As registered Industrial pharmacist and QP, Birk has 20+ years experience in the industry. He has held Leadership roles in Manufacturing, Quality Assurance, Site Management, Supply Chain Management, Logistics and Distribution and have lived and worked in Belgium, UK and Japan. Birk has worked closely with Commercial, to develop innovative and value adding distribution and supply chain solutions and has led multicultural teams and projects across EMEA, Asiapac and globally. He has been a member of Country Senior Leadership Teams in Belgium and Japan.

Birk’s current role in Global Supply Chain and Strategy focuses on transforming our supply chains into E2E Value Chains and ensures the capabilities we need to be successful in the future are in place. Birk works in the UK but lives in Belgium with his wife and 2 sons (Thomas and Brent). He likes skiing, mountain biking and is trying to play golf.


Christopher is responsible for all network planning related processes of Boehringer Ingelheim. He ensures the support, harmonization, improvement and implementation of global processes in the area of Demand Planning, Replenishment Planning, Inventory Planning and Target Setting, Sales & Operations Planning, Supply Chain Modelling and Supply Chain Design. Before Christopher joined Boehringer Ingelheim, he has worked as Supply Chain Planning consultant for several companies in the pharmaceutical and chemical industry.

Janice KiteTraceability Director Healthcare, Gs1

Prior to undertaking the assignment with GS1 Global Office to facilitate the development of process and technical Traceability standards, Janice was a senior Manager with responsibility for eBusiness for Johnson & Johnson’s UK Medical Device and



Scott operates within the Supply Chain sub competency; specialising in Pharmaceuticals and Life Science industry organisational change and improvement programs his experience covers the technical delivery, improvement and strategy levers of the operational environment.


Olivier Simonnot has been working for Sensitech Inc., UTC Building & Industrial Systems, a unit of United Technologies Corp., for seven years and currently holds the position of Strategic Market Manager, Life Sciences EMEA. He previously held several positions in Marketing and Product Management in several international technology oriented companies.

He holds a Master of Science in Telecommunications from the French engineering school ESIGETEL and a Master in Business Administration from the Rotterdam School of Management. He is an active member of the French Cold Chain Association, participated in the sub-commission on Metrology and Risk Assessment and is currently active in the Last Mile and New EU GDP working groups.




08.00 registration

09.00 chairperson’s opening remarks

PHARMACEUTICAL-DISTRIBUTIoN LANDSCAPE & REGULAToRY MATTERS

prEsEntation

09.10

how the European pharmaceutical-distribution landscape is today and how Will it affect commercial activities in Europe?Johnathon MarshallPharma & Life Sciences Advisory partner, pwc

prEsEntation

09.50

What trends are proving as catalysts for distribution companies and What Must pharmaceutical companies do to preserve their profit Margins?How can pharmaceutical companies reassert

themselves as key players in the distribution process?

Will acquisition of one or more wholesalers provide pharmaceutical companies the edge they need to remain profitable?

How pharmaceutical companies can enhance patient safety by increasing their control of drug distribution?

10.30

strategic transformation of supply chainsBirk vanderweeenHead of Supply Planning Analytics, Global Supply Chain & Strategy, astraZEnEca

11.10 Morning Break & networking

prEsEntation

11.40

how has the new European Good distribution practice (Gdp) affect pharmaceutical companies in its supply chains?What roles do pharmaceutical companies play in

preparing for inspections concerning the new GDP guidelines and what must be done to collaborate with their supply chain providers?

How has the requirement of temperature controlled handling and storage for pharmaceuticals change the industry and what must the industry do to remain competitive?

How the pharmaceutical distribution regulation in Europe is now complicated further by the rapid growth of internet and mail order pharmacy?

prEsEntation

12.20

improve planning capabilities and Eliminating Waste in supply chainsHow can advanced planning capabilities contribute

to reduce supply chain costs and improve supply chain performance?

How can inventory strategies and planning approaches address market requirements and supply chain characteristics?


13.00 networking lunch

prEsEntation

14.00

Gs1 standards: Foundational to regulatory compliance and improving the Efficiency of your supply chainDaily interaction is natural and unnoticedThe latest in GS1 developmentsEnabling regulatory compliance, supply chain

security and patient safetyJanice KiteTraceability Director Healthcare, Gs1

prEsEntation

14.40

the European stakeholder Model (EsM) – the development of a European Medicines verification system (EMvs)Falsified Medicines Directive and its delegated act on

safety features – what its mean for manufacturers, wholesalers and pharmacies

Establishing a European Medicines Verification System (EMVS) – what has been done so far

Making the European Medicines Verification system (EMVS) work in practice at European and national levels

EU hub and first national level experiences


15.20 tea Break & networking

prEsEntation

15.50

latest updates on Europe’s pharmaceutical supply chain landscapeHow will the Falsified Medicines Directive (FMD)

in Europe increase the significance of local agency oversight and the importance of strong supplier relationships?

How will the USFDA launch of a new supply chain initiative with EU counterparts improve the quality of pharmaceutical products?


panEl discussion

16.30

Globalisation and its Effects on regulation of the pharmaceutical supply chainHow can pharmaceutical companies develop

new business opportunities and reduce costs by diversifying the manufacturing supply chain?

How can pharmaceutical companies manage their supply chain amidst regulations and compliance, ethics, CSR, social and environmental aspects of emerging markets?

panEllists:


17.10 chairperson’s closing remark & End of day 1

DAY oNE CoNGRESS • Thursday, 11 december 2014


08.00 registration

09.00 chairperson’s opening remarks

SUPPLY CHAIN PLANNING & FoRECASTING

prEsEntation

09.10

Key trends driving the need for supply chain securityIntentional adulteration, cargo theft, counterfeitingImplementing an end-to-end proactive

pharmaceutical supply chain security programProduct traceabilityCompliance with corporate and regulatory group

standards


prEsEntation

09.50 asia outlook: Managing supply chain risk in asia

10.30 Morning Break & networking

prEsEntation

11.00

clinical and commercial drug supply chain Management - concordances and differencesHow the use of SAP IT solutions for clinical supply

chain management ensures integration with commercial supply chain

Particularities of clinical supply chain compared with commercial supply chain dependent on clinical development phase

Optimisation and risk avoidance of clinical supply chain supported by simulation

Clinical supply chain as pioneer for avoiding fake drugs


prEsEntation

11.40

hand-in-hand: how can choosing the right partner Ease the supply chain for pharmaceutical companies?What are the criteria pharmaceutical companies are

looking for when partnering with service providers? How can creating a network of third-party suppliers

generate a functional profitable system for pharmaceutical companies?

prEsEntation

12.20

integrity of the pharmaceutical supply chain: delivering safe and Effective Medication therapy to patientsHow can healthcare providers meet the challenges

of drug shortages? How can healthcare providers ensure product

integrity of medication? How well do online pharmacies provide information

to patients and what must pharmacies do to ensure safe and efficacy medicine to patients?

13.00 networking lunch

TECHNoLoGY & THE FUTURE oF THE PHARMACEUTICAL SUPPLY CHAIN

prEsEntation

14.00

the role of technology in European supply chain securityProduct and packaging security – authentication Product verification – track and traceHow can timely access to various emerging

technologies increase the efficiency of the manufacturing and distribution functions?

prEsEntation

14.40

temperature sensitive products supply chain integrityReview of Industry Trends and Increased Global

Regulatory RequirementsReview of Available Industry Solutions to Meet these

RequirementsThe Benefits of Continuous Process Improvement


15.20 tea Break & networking

prEsEntation

15.50

Managing healthcare delivery channels in the specialty MarketWhat is the specialty market outlook?How is the market delivering care and therapies to

patients?How can the pharmacy play a role within the

specialty healthcare provision?

Michele ingravalloDirector of Business Innovation and Transformation,alliancE Boots

prEsEntation

16.30

steering the Future of the healthcare supply chain What are the forces reshaping the environment in

which the industry operates and dictating the need for a different sort of supply chain?


17.10 chairperson’s closing remark & End of conference

DAY Two CoNGRESS • Friday, 12 december 2014


Terms and Conditions of Booking

Formation anD incorporation:

There is a 50% liability on all bookings once made, whether by fax, email or by post. Receipt of this booking form, inclusive or exclusive of payment constitutes formal agreement to attend and acceptance of the terms and conditions stated and are sold on a firm sales basis.

payment terms:

Paradigm Global Events Ltd requires full payment of the amount to be made at the time of booking via credit card. We reserve the right to decline any booking for the event. If payment is not made at the time of the booking an event, then an invoice will be issued and must be paid in full within 14 days from the date of the booking stated on the invoice and immediately prior to the event. A credit card guarantee may be requested if the full payment has not been received in full before the event and payment will be taken before entry to the event. We are unable to allow a delegate to attend an event or have access to the Document Portal unless payment has been received in full by us prior to commencement of the event. Paradigm Global Events reserves the right to charge interest on unpaid invoices.

cancellation:

The event organized by Paradigm Global Events Ltd, a limited liability company formed under English company law and registered in the UK. Cancellations received in writing more than 45 days before the conference date, will be eligible for 50% of the due less a £75 administration fee. If you are unable to send substitution then Cancellations must be made in writing. Cancellations made less than 45 days before the event date will not be entitled to a refund.

SubSTITuTIONS/NAMEChANGES:

If you are unable to attend you may nominate, in writing, another delegate to take your place any time prior to the start of the events. Two or more delegates may not share a place at an event. Please make separate bookings for each delegate.

alterations:

Paradigm Global Events Ltd reserves the right to make alterations to the event / executive briefing content, timing, speakers or program and venues beyond our control. The event may be postponed or cancelled due to unforeseen events beyond the control of Paradigm Global Events Ltd. We have no liability for any loss of trade or profit occurring to the customer as a result of a charge or cancellation. Paradigm Global Events Ltd will not accept liability for any transport disruption or individual transport delays and in such circumstances the normal cancellation restrictions apply.

Data protection:

The information that we collect and store relating to you is primarily used to enable us to provide our services to you, to respond to your inquiries about our offerings, and to offer you other products, programs or services that we believe may be of interest to you. We sometimes use such information to communicate with you. If you choose to submit content for event publication or event program, we may publish your name and other information you have provided to us. If you are a previous or existing customer, we may contact you with information about products and services similar to those, which were the subject of a previous sale to you. Furthermore, we may use your data, or permit selected third parties to use your data, so that you can be provided with information about unrelated products and services which we consider may be of interest to you. We or they may contact you about these products and services by any methods that you consented at the time your information was collected. As set out above, we are committed to safeguarding your personal information. Whenever you provide such information, we are legally obliged to use your information in line with all laws concerning the protection of personal information, including the Data Protection Act 1998 (these laws are referred to collectively in this Privacy Policy as the “data protection laws”

Fee:

The event fee includes lunch, refreshments and conference documents provided on the day. This fee does not include travel, hotel accommodation, transfers or insurance.

payment oF invoice:

Our aim is to establish and maintain a long-term business relationship with all our clients and customers, however failure to pay in accordance with clause causes us significant problems and expense in chasing late payers. For late payers we will take action to enforce full payment of the invoice, and without prejudice any other rights, to terminate the contract with you in respect of any future supplies and to compensation for debt recovery cost under “The Late Payment of Commercial Debts (Interest)” Act 1998 as amended and supplemented by “The Late Payment of Commercial Debts Regulations 2002”. In jurisdictions where this may not apply you accept that equivalent interest (8% above UK base rate) and debt recovery fees (minimum £40) will be payable to offset our costs in this matter. We may set and vary credit limits from time to time and may not accept any further orders if such credit limits are exceeded. If you have a problem with any product or service please contact us immediately and we will try and resolve the issue. you should however pay the invoice in full by the due date to prevent further action!

Standard Price Per Delegate:

conference £1299 + vat

distribution of promotional literature £700 + vat

Distribution of your company’s promotional literature to all the attendees

early birD DiscoUnt booK beFore31 oct 2014

booK beFore28 nov 2014

conFErEncE £999 + vat £1149 + vat

date of Booking:

title:

Forename: surname:

company:

Job title:

department / division:

Main switchboard number:

address:

post /Zip code:

direct line: direct Fax:

Mobile:

direct Email address:

Signature:

I confirm that I have read and agree to the terms and conditions of the booking.

Please debit my credit card:

Mastercard visa american Express

card number:

Security number 3digits security on reserve of card. 4 digits for Amex at the front

Methods of payment: Payment must be made in sterling

By Electronic Bank transfer: Please transfer the full funds to Paradigm Global Events Ltd using the following account details:

paradiGM GloBal EvEnts ltdA/C: Paradigm Global Events LtdRoyal Bank of Scotland Sort Code: 160058Account Number: 11010989Royal Bank of Scotland 40 Islington High Street London, N1 8xB, UKSwift Code: RBOSGB2L • IBAN: GB93 RBOS 16005811010989

By phone: Call us on +44 (0) 207193 3485 with your credit card details

Registration Form

Pharma End-to-End Supply Chain 2014ThuRSDAy–FRIDAy•11–12DECEMbER2014Hilton lonDon Kensington Hotel, lonDon, UniteD KingDom

Book Now!hotEl discount codE availaBlE noW,

liMitEd only & By First coMEFirst sErvE Basis!

pharma end to end supply chain cogress 2014 11-12 december

Marketing

europe supply chain

supply leader

global supply chain

pharmaceutical end

pharmaceutical products

pharmaceutical sector

pharmaceutical spending

key trends